Estimation of respiratory syncytial virus-associated hospital admissions in five European countries: a modelling studyResearch in context

Summary: Background: Respiratory syncytial virus (RSV) can cause severe disease, notably among infants, older adults, and individuals with comorbidities. Non-systematic testing and differences in coding practices affect direct measures of the hospital disease burden. We aim to tackle this issue and...

Full description

Saved in:
Bibliographic Details
Main Authors: Caroline Klint Johannesen, David Gideonse, Richard Osei-Yeboah, Toni Lehtonen, Ombeline Jollivet, Rachel A. Cohen, Arantxa Urchueguía-Fornes, María Herrero-Silvestre, Mónica López-Lacort, Rolf Kramer, Thea K. Fischer, Terho Heikkinen, Harish Nair, Harry Campbell, Michiel van Boven, Hanna Nohynek, Anne Teirlinck, Louis Bont, Peter Openshaw, Andrew Pollard, Veena Kumar, Elizabeth Begier, Jim Janimak, Jenny Hendrix, Alejandro Orrico Sánchez, Eva Molero
Format: Article
Language:English
Published: Elsevier 2025-04-01
Series:The Lancet Regional Health. Europe
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666776225000195
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825206861270351872
author Caroline Klint Johannesen
David Gideonse
Richard Osei-Yeboah
Toni Lehtonen
Ombeline Jollivet
Rachel A. Cohen
Arantxa Urchueguía-Fornes
María Herrero-Silvestre
Mónica López-Lacort
Rolf Kramer
Thea K. Fischer
Terho Heikkinen
Harish Nair
Harry Campbell
Michiel van Boven
Harish Nair
Hanna Nohynek
Anne Teirlinck
Louis Bont
Peter Openshaw
Andrew Pollard
Veena Kumar
Elizabeth Begier
Jim Janimak
Jenny Hendrix
Rolf Kramer
Alejandro Orrico Sánchez
Eva Molero
author_facet Caroline Klint Johannesen
David Gideonse
Richard Osei-Yeboah
Toni Lehtonen
Ombeline Jollivet
Rachel A. Cohen
Arantxa Urchueguía-Fornes
María Herrero-Silvestre
Mónica López-Lacort
Rolf Kramer
Thea K. Fischer
Terho Heikkinen
Harish Nair
Harry Campbell
Michiel van Boven
Harish Nair
Hanna Nohynek
Anne Teirlinck
Louis Bont
Peter Openshaw
Andrew Pollard
Veena Kumar
Elizabeth Begier
Jim Janimak
Jenny Hendrix
Rolf Kramer
Alejandro Orrico Sánchez
Eva Molero
author_sort Caroline Klint Johannesen
collection DOAJ
description Summary: Background: Respiratory syncytial virus (RSV) can cause severe disease, notably among infants, older adults, and individuals with comorbidities. Non-systematic testing and differences in coding practices affect direct measures of the hospital disease burden. We aim to tackle this issue and estimate RSV-associated respiratory hospital admissions through time series modelling of hospital admissions. Methods: The number of RSV hospital admissions in Denmark, England, Finland, the Netherlands, and Spain were estimated with attribution analyses, using age-specific respiratory tract infection (RTI) admissions combined with virological data, both from routinely collected healthcare data. Analyses covered the years 2016–2023. Findings: The attributed incidence of RSV per 100,000 children 0–2 months ranged from 1715 in Denmark to 3842 in England. In older adults, substantial differences in the incidence of ICD-10 coded RSV hospitalisations were found, while the attributed RSV incidence was more comparable, ranging from approximately 100 per 100,000 in adults 65–74 years to 200 per 100,000 persons 75–84 years and 500 per 100,000 persons 85 years and older. Interpretation: RSV-attributed time series exhibit a high degree of synchronicity between participating countries, suggesting that this method for attribution addresses the known issues with underdiagnosis and misclassification. In the older age groups, a substantial proportion of RTI hospitalisations is attributed to RSV, underscoring the relevance of RSV as a cause of severe respiratory infections. Funding: This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement 101034339. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
format Article
id doaj-art-3e59a2f5a9504d2da3fe245b4c281b08
institution Kabale University
issn 2666-7762
language English
publishDate 2025-04-01
publisher Elsevier
record_format Article
series The Lancet Regional Health. Europe
spelling doaj-art-3e59a2f5a9504d2da3fe245b4c281b082025-02-07T04:48:25ZengElsevierThe Lancet Regional Health. Europe2666-77622025-04-0151101227Estimation of respiratory syncytial virus-associated hospital admissions in five European countries: a modelling studyResearch in contextCaroline Klint Johannesen0David Gideonse1Richard Osei-Yeboah2Toni Lehtonen3Ombeline Jollivet4Rachel A. Cohen5Arantxa Urchueguía-Fornes6María Herrero-Silvestre7Mónica López-Lacort8Rolf Kramer9Thea K. Fischer10Terho Heikkinen11Harish Nair12Harry Campbell13Michiel van Boven14Harish NairHanna NohynekAnne TeirlinckLouis BontPeter OpenshawAndrew PollardVeena KumarElizabeth BegierJim JanimakJenny HendrixRolf KramerAlejandro Orrico SánchezEva MoleroDepartment of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark; Department of Clinical Research, North Zealand University Hospital, Capital Region, Denmark; Corresponding author. Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.Centre for Infectious Disease Control, National Institute for Public Health and the Environment, the NetherlandsCentre for Global Health, Usher Institute, The University of Edinburgh, Edinburgh, United KingdomDepartment of Health Security, Finnish Institute for Health and Welfare, Helsinki, FinlandSanofi, Lyon, FranceGSK, Rockville, MD, United StatesVaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO), Valencia, Spain; CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III, SpainVaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO), Valencia, SpainVaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO), Valencia, Spain; CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III, SpainSanofi, Lyon, FranceDepartment of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark; Department of Clinical Research, North Zealand University Hospital, Capital Region, Denmark; Department of Public Health, University of Copenhagen, DenmarkDepartment of Pediatrics, University of Turku and Turku University Hospital, Turku, FinlandCentre for Global Health, Usher Institute, The University of Edinburgh, Edinburgh, United KingdomCentre for Global Health, Usher Institute, The University of Edinburgh, Edinburgh, United KingdomCentre for Infectious Disease Control, National Institute for Public Health and the Environment, the Netherlands; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands; Corresponding author. Centre for Infectious Disease Control, National Institute for Public Health and the Environment, the Netherlands.Summary: Background: Respiratory syncytial virus (RSV) can cause severe disease, notably among infants, older adults, and individuals with comorbidities. Non-systematic testing and differences in coding practices affect direct measures of the hospital disease burden. We aim to tackle this issue and estimate RSV-associated respiratory hospital admissions through time series modelling of hospital admissions. Methods: The number of RSV hospital admissions in Denmark, England, Finland, the Netherlands, and Spain were estimated with attribution analyses, using age-specific respiratory tract infection (RTI) admissions combined with virological data, both from routinely collected healthcare data. Analyses covered the years 2016–2023. Findings: The attributed incidence of RSV per 100,000 children 0–2 months ranged from 1715 in Denmark to 3842 in England. In older adults, substantial differences in the incidence of ICD-10 coded RSV hospitalisations were found, while the attributed RSV incidence was more comparable, ranging from approximately 100 per 100,000 in adults 65–74 years to 200 per 100,000 persons 75–84 years and 500 per 100,000 persons 85 years and older. Interpretation: RSV-attributed time series exhibit a high degree of synchronicity between participating countries, suggesting that this method for attribution addresses the known issues with underdiagnosis and misclassification. In the older age groups, a substantial proportion of RTI hospitalisations is attributed to RSV, underscoring the relevance of RSV as a cause of severe respiratory infections. Funding: This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement 101034339. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.http://www.sciencedirect.com/science/article/pii/S2666776225000195RSVRespiratory tract infectionHospital admissionsNational register-based studyTime series analysisBurden of disease
spellingShingle Caroline Klint Johannesen
David Gideonse
Richard Osei-Yeboah
Toni Lehtonen
Ombeline Jollivet
Rachel A. Cohen
Arantxa Urchueguía-Fornes
María Herrero-Silvestre
Mónica López-Lacort
Rolf Kramer
Thea K. Fischer
Terho Heikkinen
Harish Nair
Harry Campbell
Michiel van Boven
Harish Nair
Hanna Nohynek
Anne Teirlinck
Louis Bont
Peter Openshaw
Andrew Pollard
Veena Kumar
Elizabeth Begier
Jim Janimak
Jenny Hendrix
Rolf Kramer
Alejandro Orrico Sánchez
Eva Molero
Estimation of respiratory syncytial virus-associated hospital admissions in five European countries: a modelling studyResearch in context
The Lancet Regional Health. Europe
RSV
Respiratory tract infection
Hospital admissions
National register-based study
Time series analysis
Burden of disease
title Estimation of respiratory syncytial virus-associated hospital admissions in five European countries: a modelling studyResearch in context
title_full Estimation of respiratory syncytial virus-associated hospital admissions in five European countries: a modelling studyResearch in context
title_fullStr Estimation of respiratory syncytial virus-associated hospital admissions in five European countries: a modelling studyResearch in context
title_full_unstemmed Estimation of respiratory syncytial virus-associated hospital admissions in five European countries: a modelling studyResearch in context
title_short Estimation of respiratory syncytial virus-associated hospital admissions in five European countries: a modelling studyResearch in context
title_sort estimation of respiratory syncytial virus associated hospital admissions in five european countries a modelling studyresearch in context
topic RSV
Respiratory tract infection
Hospital admissions
National register-based study
Time series analysis
Burden of disease
url http://www.sciencedirect.com/science/article/pii/S2666776225000195
work_keys_str_mv AT carolineklintjohannesen estimationofrespiratorysyncytialvirusassociatedhospitaladmissionsinfiveeuropeancountriesamodellingstudyresearchincontext
AT davidgideonse estimationofrespiratorysyncytialvirusassociatedhospitaladmissionsinfiveeuropeancountriesamodellingstudyresearchincontext
AT richardoseiyeboah estimationofrespiratorysyncytialvirusassociatedhospitaladmissionsinfiveeuropeancountriesamodellingstudyresearchincontext
AT tonilehtonen estimationofrespiratorysyncytialvirusassociatedhospitaladmissionsinfiveeuropeancountriesamodellingstudyresearchincontext
AT ombelinejollivet estimationofrespiratorysyncytialvirusassociatedhospitaladmissionsinfiveeuropeancountriesamodellingstudyresearchincontext
AT rachelacohen estimationofrespiratorysyncytialvirusassociatedhospitaladmissionsinfiveeuropeancountriesamodellingstudyresearchincontext
AT arantxaurchueguiafornes estimationofrespiratorysyncytialvirusassociatedhospitaladmissionsinfiveeuropeancountriesamodellingstudyresearchincontext
AT mariaherrerosilvestre estimationofrespiratorysyncytialvirusassociatedhospitaladmissionsinfiveeuropeancountriesamodellingstudyresearchincontext
AT monicalopezlacort estimationofrespiratorysyncytialvirusassociatedhospitaladmissionsinfiveeuropeancountriesamodellingstudyresearchincontext
AT rolfkramer estimationofrespiratorysyncytialvirusassociatedhospitaladmissionsinfiveeuropeancountriesamodellingstudyresearchincontext
AT theakfischer estimationofrespiratorysyncytialvirusassociatedhospitaladmissionsinfiveeuropeancountriesamodellingstudyresearchincontext
AT terhoheikkinen estimationofrespiratorysyncytialvirusassociatedhospitaladmissionsinfiveeuropeancountriesamodellingstudyresearchincontext
AT harishnair estimationofrespiratorysyncytialvirusassociatedhospitaladmissionsinfiveeuropeancountriesamodellingstudyresearchincontext
AT harrycampbell estimationofrespiratorysyncytialvirusassociatedhospitaladmissionsinfiveeuropeancountriesamodellingstudyresearchincontext
AT michielvanboven estimationofrespiratorysyncytialvirusassociatedhospitaladmissionsinfiveeuropeancountriesamodellingstudyresearchincontext
AT harishnair estimationofrespiratorysyncytialvirusassociatedhospitaladmissionsinfiveeuropeancountriesamodellingstudyresearchincontext
AT hannanohynek estimationofrespiratorysyncytialvirusassociatedhospitaladmissionsinfiveeuropeancountriesamodellingstudyresearchincontext
AT anneteirlinck estimationofrespiratorysyncytialvirusassociatedhospitaladmissionsinfiveeuropeancountriesamodellingstudyresearchincontext
AT louisbont estimationofrespiratorysyncytialvirusassociatedhospitaladmissionsinfiveeuropeancountriesamodellingstudyresearchincontext
AT peteropenshaw estimationofrespiratorysyncytialvirusassociatedhospitaladmissionsinfiveeuropeancountriesamodellingstudyresearchincontext
AT andrewpollard estimationofrespiratorysyncytialvirusassociatedhospitaladmissionsinfiveeuropeancountriesamodellingstudyresearchincontext
AT veenakumar estimationofrespiratorysyncytialvirusassociatedhospitaladmissionsinfiveeuropeancountriesamodellingstudyresearchincontext
AT elizabethbegier estimationofrespiratorysyncytialvirusassociatedhospitaladmissionsinfiveeuropeancountriesamodellingstudyresearchincontext
AT jimjanimak estimationofrespiratorysyncytialvirusassociatedhospitaladmissionsinfiveeuropeancountriesamodellingstudyresearchincontext
AT jennyhendrix estimationofrespiratorysyncytialvirusassociatedhospitaladmissionsinfiveeuropeancountriesamodellingstudyresearchincontext
AT rolfkramer estimationofrespiratorysyncytialvirusassociatedhospitaladmissionsinfiveeuropeancountriesamodellingstudyresearchincontext
AT alejandroorricosanchez estimationofrespiratorysyncytialvirusassociatedhospitaladmissionsinfiveeuropeancountriesamodellingstudyresearchincontext
AT evamolero estimationofrespiratorysyncytialvirusassociatedhospitaladmissionsinfiveeuropeancountriesamodellingstudyresearchincontext